26-Jan-2016 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC. They are heavily reliant on our expertise with using the Freedom of Information Act. FlowServe $FLS Disclosed SEC Investigation, But With...
Disclosure Insight - Commentary & Analysis
25-Jan-2016 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC. They are heavily reliant on our expertise with using the Freedom of Information Act. Peabody Energy Corporation $BTU Confirmed, Undisclosed SEC...
10-Dec-2015 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC. They are heavily reliant on our expertise with using the Freedom of Information Act. Probes Reporter is in the process of converting to a paid...
8-Dec-2015 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC. They are heavily reliant on our expertise with using the Freedom of Information Act. Probes Reporter is in the process of converting to a paid...
16-Nov-2015 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC. They are heavily reliant on our expertise with using the Freedom of Information Act. Probes Reporter is in the process of converting to a paid...
12-Nov-2015 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC. They are heavily reliant on our expertise with using the Freedom of Information Act. Probes Reporter is in the process of converting to a paid...
23-Oct-2015 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC. Valeant Pharmaceuticals $VRX $116.16 Expect an array of protracted, distracting, and expensive investigations. As of 30-...
13-Oct-2015 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC. Soon Probes Reporter will become a paid subscription service. At that time you should expect both timing and access to our content that you enjoy...